Ken Chen
个人简介
教育背景
2004.12
University of Illinois, Urbana-Champaign, Illinois, US Ph.D Electrical and Computer Engineering
1996.12
Tsinghua University, Beijing, CN BE Precision Instruments
工作经历
2026.01 – 至今
MDA 2024-05-01 Investigation Committee, The University of Texas MD Anderson Cancer Center, Houston, TX
member, Promotion and Tenure Committee-Research (PTC-R), The University of Texas MD Anderson Cancer Center, Houston, TX
2026.01 – 至今
The University of Texas MD Anderson Cancer Center, Houston, TX
Faculty member, Executive Research Compliance Committee (ERCC), The University of Texas MD Anderson Cancer Center, Houston, TX
2026.01 – 至今
Frontiers in immunology
Guest editor, Frontiers in immunology
2025.01 – 至今
The University of Texas MD Anderson Cancer Center, Houston, TX
Member, General Oncology Chair search committee, The University of Texas MD Anderson Cancer Center, Houston, TX
2025.01 – 至今
Genome Medicine
Editorial Board member, Genome Medicine
2025.01 – 至今
Frontiers in Immunology
Guest editor, Frontiers in Immunology
2024.01 – 至今
Genomics, Proteomics & Bioinformatics (GPB)
Editorial Board Member, Genomics, Proteomics & Bioinformatics (GPB)
2022.01 – 至今
The University of Texas MD Anderson Cancer Center, Houston, TX
Member, Faculty Search Committee, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX
2022.01 – 2023.12
Frontiers in Oncology
Guest editor, Frontiers in Oncology
2022.01 – 至今
Frontiers Immunology
Associate Editor, Frontiers Immunology
2021.01 – 至今
Emerging Topics in Life Sciences
Editor, Emerging Topics in Life Sciences
2017.01 – 2018.12
The University of Texas MD Anderson Cancer Center, Houston, TX
Member, Faculty Search Committee Dept. Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX
2016.01 – 2021.12
The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Bioinformatics and Computational Biology
2016.01 – 至今
The University of Texas MD Anderson Cancer Center, Houston, TX
Member, Faculty Search Committee, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
2011.01 – 2016.12
The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Quantitative Sciences
2009.01 – 2011.12
Washington University, St. Louis, MO
Research Instructor, Genetics
荣誉奖项
- Elected Fellow, Asia-Pacific Artificial Intelligence Association (AAIA)(2025 - Present)|Asia-Pacific Artificial Intelligence Association (AAIA)
- Elected Fellow, American Institute of Medical and Biological Engineering (AIMBE)(2025 - Present)|American Institute of Medical and Biological Engineering (AIMBE)
- MD Anderson Celebration of Faculty Excellence in Research Excellence(2024)|MD Anderson Cancer Center
- Mentor’s Choice Award(2024)|Biomedical Data Science Innovation Lab
- 2024 NIH Common Fund Complement-ARIE (Complement Animal Research In Experimentation) award(2024)|NIH
- 1st place in subtask 2 of international AI chemotimeline reconstruction challenge from clinical narratives(2024)|NIH
- Highest Commendation(2023)|University of Texas Graduate School of Biomedical Science
- Robert M. Chamberlain Distinguished Mentor Award(2023)|MD Anderson Cancer Centre Postdoctoral Association
- "Wall of Science" Publication Gallery(2023)|The University of Texas MD Anderson Cancer Center
- President’s Recognition of Faculty Excellence(2021)|MD Anderson Cancer Center
- Highly Cited Researcher 2020(2020)|Clarivate
- Andrew Sabin Family Fellow(2016 - 2018)
- Nominee, Robert M. Chamberlain Distinguished Mentor Award(2016)|MD Anderson Cancer Center
- Best performer in ICGC-TCGA DREAM 8.5 Somatic Mutation Calling Challenge(2014)|dreamchallenge.org
- Senior Member, Institute of Electrical and Electronics Engineers(2009 - Present)
- Sigma Xi(2009)
- Phi Kappa Phi(2003)|University of Illinois at Urbana-Champaign
- 1st place in high school software competition(1990)|The science and technology society, Sichuan Province, China
晚期低级别浆液性癌患者新辅助fulvestrant联合abemaciclib治疗的初步转化研究
与LRRK2突变和帕金森病相关的血液和脑脊液中的可溶性免疫因子谱
整合性分析策略指导套细胞淋巴瘤个性化治疗的初步研究
基因组与表观基因组特征能够区分临床级样本中侵袭性的嗜酸性肾细胞癌与惰性的肾源性肿瘤。
经皮外引流治疗儿童胰腺假性囊肿的疗效及复发危险因素
大型细胞图谱提供的见解、机遇与挑战
Coco-st检测空间转录组数据集中的全局和局部生物结构
单目建模在不利光照条件下的非合作空间目标
基于成像的单细胞分辨率空间转录组学分析平台比较:使用福尔马林固定石蜡包埋肿瘤样本
LSGI:可解释的空间梯度分析用于空间转录组学数据
全基因组CRISPR筛选鉴定出增强CAR-NK细胞抗肿瘤效力的关键靶点
同日出院在球囊肺动脉成形术中的安全性
陈,W.; 张,P.; Tran,T.N.; 肖Y.; 李S.; Shah,V.V.; 程H.; Brannan,K.W.; Youker,K.; Lai,L.; 等. 一种用于连接组织病理学与空间转录组学的视觉组学基础模型。Nat. Methods 2025, 22, 1568–1582. [Google Scholar] [CrossRef] [PubMed]
人类和小鼠肺腺癌前体物的空间与多组学分析揭示TIM-3可作为癌症拦截的潜在靶点
黑色素瘤脑转移患者总体生存相关的分子和临床特征的综合分析
Phytophthora infestans接种后,晚疫病抗性番茄根际土壤微生物群落的多样性与组成
表观遗传启动子特征和远端基因间基因调控因子的异位获得促进肝细胞癌发生:Planet研究
阐明Venetoclax耐药AML中的转录异质性

